CSIMarket
 

Opko Health Inc   (NASDAQ: OPK)

Opko Health Inc 's

Competitiveness




 

OPK Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Opko Health Inc reported Revenue increase in the 2 quarter 2026 by 4.32 % year on year.
The revenue growth was below Opko Health Inc 's competitors' average revenue growth of 5.59 %, achieved in the same quarter.

List of OPK Competitors





Revenue Growth Comparisons




Net Income Comparison


Opko Health Inc , slower than the average decrease reported by the company's competitors of -75.81 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -75.81 %

<<  OPK Stock Performance Comparisons



  

Overall company Market Share Q2 2026

Overall company revenue, grew less, than total company revenues, at 4.32 % and company approximately market share, declined to 0.22 %.
<<  More on OPK Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Opko Health Inc




Allarity Therapeutics Inc
Share Performance



+0.71%
Over The Past 5 Days



Allarity Therapeutics Inc
Profile

Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.

More about Allarity Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 22.593 mill. $ - mill. $ -12.334 mill.


Novartis Ag
Share Performance



+15.48%
This Year



Novartis Ag
Profile

Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.

More about Novartis Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 312,780.450 mill. $ 70,725.000 mill. $ 17,991.000 mill.


Sanofi
Share Performance



+4.41%
This Quarter



Sanofi
Profile

Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.

More about Sanofi's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 108,441.088 mill. $ 52,321.040 mill. $ 8,793.120 mill.


Astrazeneca Plc
Share Performance



-10.23%
This Year



Astrazeneca Plc
Profile

AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.

More about Astrazeneca Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 127,068.700 mill. $ 73,196.000 mill. $ 12,681.000 mill.


Viatris Inc
Share Performance



+35.47%
This Year



Viatris Inc
Profile

Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.

More about Viatris Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 19,636.504 mill. $ 14,737.300 mill. $ -410.700 mill.

128 more competitors available

Sign in to see all competitors

Sources: Opko Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Opko Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.